Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus is a research paper published in Journal of Virology (2020). On theSindex it has a DataRank of 27.7. It has been cited 4,662 times, with 200 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.3
From this paper's citation signal
Citation Network Contribution
26.5
From 200 citing papers with measurable signal
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: R01AI089728
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: R01AI110700
National Institutes of Health
Grant: 1R01AI110700-01A1
Mechanisms of MERS-CoV Entry, Cross-species Transmission and Pathogenesis
National Institutes of Health
Grant: 5R01AI089728-07
Receptor recognition and cell entry of coronaviruses
FWCI
106.33
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of COVID-19: viral–host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection
Additional file 2 of COVID-19: viral–host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection
Additional file 1 of Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care
Additional file 1 of Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care
Additional file 2 of Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care
Additional file 2 of Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care
Additional file 1 of The comparison of epidemiological characteristics between confirmed and clinically diagnosed cases with COVID-19 during the early epidemic in Wuhan, China
Additional file 1 of The comparison of epidemiological characteristics between confirmed and clinically diagnosed cases with COVID-19 during the early epidemic in Wuhan, China
Additional file 1 of Natural products provide a new perspective for anti-complement treatment of severe COVID-19: a review
Additional file 1 of Natural products provide a new perspective for anti-complement treatment of severe COVID-19: a review
Additional file 1 of SARS-CoV-2 host cell entry: an in silico investigation of potential inhibitory roles of terpenoids
Additional file 1 of SARS-CoV-2 host cell entry: an in silico investigation of potential inhibitory roles of terpenoids
Additional file 1 of Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19
Additional file 1 of Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19
Additional file 1 of Long-range enhancement of N501Y-endowed mouse infectivity of SARS-CoV-2 by the non-RBD mutations of Ins215KLRS and H655Y
Additional file 1 of Long-range enhancement of N501Y-endowed mouse infectivity of SARS-CoV-2 by the non-RBD mutations of Ins215KLRS and H655Y
Additional file 1 of A prospective longitudinal study evaluating the influence of immunosuppressives and other factors on COVID-19 in autoimmune rheumatic diseases
Additional file 1 of A prospective longitudinal study evaluating the influence of immunosuppressives and other factors on COVID-19 in autoimmune rheumatic diseases
Additional file 1 of The impact of ACE2 polymorphisms (rs1978124, rs2285666, and rs2074192) and ACE1 rs1799752 in the mortality rate of COVID-19 in different SARS-CoV-2 variants
Additional file 1 of The impact of ACE2 polymorphisms (rs1978124, rs2285666, and rs2074192) and ACE1 rs1799752 in the mortality rate of COVID-19 in different SARS-CoV-2 variants